Dr. Lise Hébert
Lise Hébert, PhD has served as our President and Chief Executive Officer and as a member of our board of directors since April 2009. Prior to joining our company, Dr. Hébert served as vice president of Corporate Communications at Bellus Health Inc., a biotechnology company, for over 10 years. She currently serves on the Life Sciences Committee of the Fédération des Chambres du Commerce du Québec.
Dr. Hébert holds a PhD in Experimental Medicine from McGill University, where her research focused on amyloidosis and during which time she also conducted research at New York University Medical School. Dr. Hébert completed her post-doctoral studies at the Lady Davis Research Institute at the Montreal Jewish General Hospital and is the author of several patents.
Mr. Mariano Rodriguez
Mariano Rodriguez, CPA, CA has served as our Chief Financial Officer and Senior Vice President of Corporate Development since November 2014 and previously served as our Vice President and Chief of Finance and Operations since August 2011.
From May 2009 to August 2011, he was the executive vice president and chief financial officer of GFI Solutions Group Inc., an information technology software and services company. From January 2005 to May 2009, he was vice president and chief financial officer of Bellus Health Inc. and previously served as vice president and chief financial officer of Galileo Genomics Inc., a biotechnology company.
He began his career at Ernst & Young LLP. Mr. Rodriguez holds a diploma in Public Accounting and a Bachelor of Commerce degree from McGill University, and is also a certified CPA, CA in Canada and CPA in the United States.
Mr. Jason Gugliuzza
Jason Gugliuzza serves as our Senior Vice-President Global Marketing and Sales since June 2017. Prior to joining our company Mr. Gugliuzza held various senior sales and marketing positions for several multinational organizations. Most recently, he served as the Senior Vice-President for Japan and Asia at Acelity.
Previously he was the Regional Vice President and Vice-President of Commercial strategy for the Emerging Markets region at Acelity working across all of the Asia, MENA and Latin American regions.
A seasoned Sales and marketing professional with twenty years working in healthcare, he has worked and lived in Europe, Asia and North America with experience of the Wound Care, Respiratory Pharmaceuticals and Dermatology segments, specifically with companies such as AstraZeneca, Smith and Nephew and ConvaTec.
Mr. Gugliuzza holds an MBA from the University of Durham, an MSc in International Business and Corporate Finance and an undergraduate degree in Economics.
Mr. Trevor Arsenault
Previously, Mr. Arsenault was Vice-President & General Manager International at Pharmascience Inc. Mr. Arsenault was also a Director for Pharmascience Korea and held senior Commercial positions from 2004 to 2010 at Bristol Myers Squibb Co., including Vice-President of Immunology, Virology, & CNS for Bristol Myers Squibb Canada Co. and Global Director of Market Access BMS Headquarters in Princeton, NJ.
Mr. Arsenault holds a Bachelor of Business Administration from University of New Brunswick.
VP of Regulatory & Quality Assurance
Daniela Jukic, PHD has served as senior director of Regulatory Affairs Compliance and Quality Assurance since 2016.
Dr. Jukic has extensive regulatory and compliance experience covering Prescription, Blood Products, Cells Tissues & Organs, OTC, Rx-to-OTC Switch, NHP, DIN to NHP transition, Medical Devices, Cosmetic and Consumer Care products.
Prior to joining our company, Dr. Jukic has over 20 years of experience in pharma as Director Regulatory Affairs and Compliance for firms such as Pfizer/Pharmacia, Merck Canada, Schering Canada/Bayer and at Hema-Quebec.
Dr. Jukic holds a PhD in Pharmacology from the Faculty of Medicine, University of Sherbrooke.
Dr. Stéphane Fauverghe
Dr. Fauverghe holds a Medical Degree from the University of Lyon and an MBA from ESSEC Business School (Paris).